Home / Share Price Target / Indramedco
INDRAMEDCO Share Price Target 2024, 2025, 2026 to 2039 With Charts
Indraprastha Medical Corporation Limited | |||
 | Symbol: INDRAMEDCO | ||
| Price: ₹432.85 | |||
| Exchange: NSE | |||
| Healthcare -> Medical Care Facilities | |||
Show Table of Contents
Table of Contents
- 1: INDRAMEDCO Brief Company Overview
- 1.1: Indraprastha Medical Corporation Limited: A Healthcare Giant in India
- 1.2: INDRAMEDCO Financial Performance
- 1.2.1: Is INDRAMEDCO A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: INDRAMEDCO Share Price Target For 2024
- 2.1.1: INDRAMEDCO Share Price Target Table For 2024
- 2.1.2: Summary: INDRAMEDCO Share Price Prediction For 2024
- 2.2: INDRAMEDCO Share Price Target For 2025
- 2.2.1: INDRAMEDCO Share Price Target Table For 2025
- 2.2.2: Summary: INDRAMEDCO Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: INDRAMEDCO Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: INDRAMEDCO Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: INDRAMEDCO Past Performance
INDRAMEDCO Brief Company Overview
```htmlIndraprastha Medical Corporation Limited: A Healthcare Giant in India
Indraprastha Medical Corporation Limited, established in 1983, is a leading provider of comprehensive hospital services in India. Based in New Delhi, the company has a strong presence across the country.
Diverse Product Range: Indraprastha Medical offers a wide range of medical services, including sugar management, genomic medicine, elder care, cardiology, oncology, emergency care, gastroenterology, neurology, orthopedics, pediatrics, ophthalmology, and more.
Industry Reputation: The company has consistently maintained a strong reputation for its quality healthcare services. Its experienced medical professionals and state-of-the-art facilities have earned it recognition as a trusted healthcare provider.
Commitment to Excellence: Indraprastha Medical is committed to providing affordable and accessible healthcare to all. Its commitment to innovation and patient care ensures that its services are constantly evolving to meet the changing needs of the healthcare industry.
Advertisement
INDRAMEDCO Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 3,914.43 Crore | Market valuation of INDRAMEDCO's shares. |
| Revenue (TTM) | 1,286.04 Crore | Total revenue generated by INDRAMEDCO over the past twelve months. |
| Net Income (TTM) | +138.23 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 16.12% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 10.74% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +13.5% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +46.8% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 7.1 | Company's total debt divided by total shareholder equity. |
| Total Debt | 33.95 Crore | Sum of INDRAMEDCO's current & long-term financial obligations. |
| Total Cash | 224.43 Crore | Total amount of liquid funds available to INDRAMEDCO. |
| Beta | 0.78 | Beta is less than 1 indicating that the INDRAMEDCO's price is less volatile than the market. |
Is INDRAMEDCO A Good Buy For Long Term?
INDRAMEDCO, a smallcap stock with a market capitalization of ₹4,129.41 Crore, has shown impressive growth in recent periods, posting a 168.36% return over the past year and a staggering 1053.52% return over the last five years. While its Q1-2024-25 results indicate strong revenue growth (13.5% QoQ) and a healthy profit margin of 10.74%, the company's low debt level (₹33.95 Crore) and significant cash balance (₹224.43 Crore) suggest a solid financial foundation. However, it's crucial to note that past performance is not indicative of future results. Further research into the company's future prospects and industry dynamics is essential before making any investment decisions. Overall, while the current data suggests a potential for growth, a more in-depth analysis is required for a definitive buy recommendation.
To predict the INDRAMEDCO's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
INDRAMEDCO Share Price Target For 2024
The line chart displays the monthly closing prices of INDRAMEDCO with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for INDRAMEDCO shares in 2024, see the table below.
Advertisement
INDRAMEDCO Share Price Target Table For 2024
| INDRAMEDCO's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 447.53 (+3.39%) | Custom Fibonacci Extension Lvl 50% |
| 2024 Target 2 | 442.75 (+2.28%) | Price Action: 14 Oct 2024 Low |
| 2024 Target 1 | 438.00 (+1.18%) | Price Action: 07 Oct 2024 High |
| Current Price | 432.85 | INDRAMEDCO's 1 share price as of Thu 17 Oct 2024 |
| Stop Loss 1 | 429.95 (-0.67%) | Price Action: Oct 2024 Low |
| Stop Loss 2 | 424.50 (-1.93%) | Price Action: 09 Oct 2024 High |
| Stop Loss 3 | 420.00 (-2.97%) | Price Action: 08 Oct 2024 High |
Summary: INDRAMEDCO Share Price Prediction For 2024
In summary, INDRAMEDCO has surged by ₹260.40, achieving a notable +151.00% increase from 1st January 2024 to 17 Oct 2024. Our analysis of INDRAMEDCO for 2024 predicts an additional rise of 1.18% to 3.39% by the end of 2024 with three potential targets T1: 438.00, T2: 442.75, T3: 447.53. Stop Loss at SL1: 429.95, SL2: 424.50, SL3: 420.00.
INDRAMEDCO has a 52-week high of ₹484.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹149.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for INDRAMEDCO.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
INDRAMEDCO Share Price Target For 2025
The line chart displays the monthly closing prices of INDRAMEDCO with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for INDRAMEDCO shares in 2025, see the table below.
Advertisement
INDRAMEDCO Share Price Target Table For 2025
| INDRAMEDCO's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 647.21 (+49.52%) | Price Action: Chart |
| 2025 Target 2 | 635.14 (+46.73%) | Price Action: Chart |
| 2025 Target 1 | 628.85 (+45.28%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 432.85 | INDRAMEDCO's 1 share price as of Thu 17 Oct 2024 |
| Stop Loss 1 | 386.29 (-10.76%) | Price Action: Aug 2024 Low |
| Stop Loss 2 | 382.43 (-11.65%) | Price Action: Chart |
| Stop Loss 3 | 375.55 (-13.24%) | Price Action: Chart |
Summary: INDRAMEDCO Share Price Prediction For 2025
In summary, INDRAMEDCO has surged by ₹260.40, achieving a notable +151.00% increase from 1st January 2024 to 17 Oct 2024. Our analysis of INDRAMEDCO for 2025 predicts an additional rise of 45.28% to 49.52% by the end of 2025 with three potential targets T1: 628.85, T2: 635.14, T3: 647.21. Stop Loss at SL1: 386.29, SL2: 382.43, SL3: 375.55.
INDRAMEDCO has a All-Time high of ₹484.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹149.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for INDRAMEDCO, we have created a specific page for that check here: INDRAMEDCO Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
INDRAMEDCO Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of INDRAMEDCO share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 19.63% over the next 15 years.
For complete year by year INDRAMEDCO long term share price target from 2024, 2025 to 2039 check the below table.
INDRAMEDCO Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | INDRAMEDCO Target | YoY Change % |
|---|---|---|
| 2024 | ₹432.85 | [Current Price] |
| 2024 | ₹493.77 | 14.07% |
| 2025 | ₹905.3 | 83.34% |
| 2026 | ₹1,270.49 | 40.33% |
| 2027 | ₹1,739.82 | 36.94% |
| 2028 | ₹1,929.75 | 10.91% |
| 2029 | ₹2,281.44 | 18.22% |
| 2030 | ₹2,806.37 | 23% |
| 2031 | ₹3,149.33 | 12.22% |
| 2032 | ₹3,725.43 | 18.29% |
| 2033 | ₹3,722.84 | -0.07% |
| 2034 | ₹4,069.12 | 9.3% |
| 2035 | ₹4,707.43 | 15.68% |
| 2036 | ₹5,028.16 | 6.81% |
| 2037 | ₹5,711.05 | 13.58% |
| 2038 | ₹5,515.94 | -3.42% |
| 2039 | ₹6,068.13 | 10.01% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
INDRAMEDCO Past Performance
- In 1997, INDRAMEDCO opening price was ₹7
- As of Thu 17 Oct 2024 the price stands at ₹432.85.
- This represents a Compound Annual Growth Rate (CAGR) of 15.87%.
- In 27 years, an investment of 10,000 would have become ₹6.18 Lakh.
As we wrap up, we hope you like our study on INDRAMEDCO share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
